comparemela.com

Latest Breaking News On - வடக்கு அமெரிக்கா ஜெநெரிக்ஸ் - Page 1 : comparemela.com

DrReddy s Laboratories Ltd (RDY) Q1 2022 Earnings Call Transcript

DrReddy s Laboratories Ltd (RDY) Q1 2022 Earnings Call Transcript
fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.

Dr Reddy s bullish on OTC products sale through Amazon, others in US

Dr Reddy s bullish on OTC products sale through Amazon, others in US
business-standard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from business-standard.com Daily Mail and Mail on Sunday newspapers.

Dr Reddy s lines up Rs 1,000 crore capex for current fiscal year

Dr Reddy s lines up Rs 1,000 crore capex for current fiscal year SECTIONS Last Updated: May 24, 2021, 01:04 PM IST Share Agencies The company remains positive about sustaining its growth trends in the current fiscal and beyond, as per a top company official. INSIGHTS NSE Explore Now NEW DELHI: Drug major Dr Reddy s Laboratories has earmarked a Capex of around Rs 1,000 crore for the current fiscal as it remains positive about sustaining its growth trends in the current fiscal and beyond, as per a top company official. The Hyderabad based firm invested about Rs 1,000 crore in the 2020-21 fiscal. The Capex will be around the same numbers, maybe a bit higher if everything goes through, Dr Reddy s Laboratories CEO Erez Israeli said in an analyst call.

Dr Reddy s earmarks capex worth Rs 1,000 cr for 2021-22 on growth outlook

Dr Reddy s earmarks capex worth Rs 1,000 cr for 2021-22 on growth outlook The Capex will be around the same numbers as the 2020-21 fiscal, maybe a bit higher if everything goes through, Dr Reddy s Laboratories CEO Erez Israeli said PTI | May 24, 2021 | Updated 13:48 IST Drug major Dr Reddy s Laboratories has earmarked a Capex of around Rs 1,000 crore for the current fiscal as it remains positive about sustaining its growth trends in the current fiscal and beyond, as per a top company official. The Hyderabad based firm invested about Rs 1,000 crore in the 2020-21 fiscal. The Capex will be around the same numbers, maybe a bit higher if everything goes through, Dr Reddy s Laboratories CEO Erez Israeli said in an analyst call.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.